| FXR | Farnesoid X receptor |
| NR | Nuclear receptor |
| BA | Bile acid |
| CDCA | Chenodeoxycholic acid |
| CYP7A1 | Cholesterol 7α-hydroxylase |
| SHP | Small heterodimer partner |
| FGF | Fibroblast growth factor |
| TGR5 | Transmembrane G protein-coupled receptor 5 |
| PBC | Primary biliary cholangitis |
| MASH | Metabolic-dysfunction-associated steatohepatitis |
| MASLD | Metabolic-dysfunction-associated steatotic liver disease |
| LDL | Low-density lipoprotein |
| UDCA | Ursodeoxycholic acid |
| T2DM | Type 2 diabetes mellitus |
| PPAR | Peroxisome proliferator-activated receptor |
| PXR | Pregnane X receptor |
| RXR | Retinoid X receptor |
| AR | Androgen receptor |
| AF2 | Activation function 2 |
| RP | Relative potency |
| HDL | High-density lipoprotein |
| TR-FRET | Time-resolved fluorescence resonance energy transfer |
| Luc | Luciferase reporter gene assay |
| HTS | High-throughput screening |
| SAR | Structure–activity relationship |
| VDR | Vitamin D receptor |
| MSC | Mesenchymal stem cell |
| LBD | Ligand-binding domain |
| SPA | Scintillation proximity assay |
| GPBAR1 | G protein-coupled bile acid receptor 1 |
| LXR | Liver X receptor |
| LTA4H | Leukotriene A4 hydrolase |
| FABP1 | Intestinal fatty acid binding protein 1 |
| URAT1 | Urate transporter 1 |
| sEH | Soluble epoxide hydrolase |
| HSD17B13 | 17-β-hydroxysteroid dehydrogenase 13 |
| LIFR | Leukemia inhibitory factor receptor |
| CDK | Cyclin-dependent kinase |
| Gly-MCA | Glycine-β-muricholic acid |
| HFD | High-fat diet |
| Asbt | Apical sodium-dependent bile acid transporter |
| RLM | Rat liver microsome |
| MLM | Mouse liver microsome |
| SMRT | Silencing mediator of retinoic acid and thyroid hormone receptor |
| NcoR1 | Nuclear receptor corepressor 1 |
| MW | Molecular weight |
| Fex | Fexaramine |